Evidence map›Paper›PMID 21222471›Full record

ArticleBiochemistry2011

Allosteric modification, the primary ATP activation mechanism of atrial natriuretic factor receptor guanylate cyclase.

Teresa Duda, Prem Yadav, Rameshwar K Sharma

Open access · greenAbstract read
In one paragraph

Article in Biochemistry, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 18 citations in OpenAlex.

  1. The discovery of hidden guanylate cyclases (GCs) in theComputational and structural biotechnology journal · 2023
    Article
  2. Review
  3. Review
  4. Article
  5. CaFrontiers in molecular neuroscience · 2018
    Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Teresa DudaResearch Division of Biochemistry, The Unit of Regulatory and Molecular Biology, Salus University, 8360 Old York Road, Elkins Park, Pennsylvania 19027, United States. tduda@salus.edu
Prem Yadav
Rameshwar K Sharma
Salus University · US

Funding

ATP-MODULATED SIGNAL TRANSDUCTION MECHANISM OF ANF-RGCR01HL084584 · NHLBI · SALUS UNIVERSITY · PI DUDA, TERESA · 2007 to 2011
$1.9M
CENTRAL INTEGRATION OF AFFERENT INPUTS BY NTS NEURONSF32HL008458 · NHLBI · UNIVERSITY OF IOWA · PI HAYWARD, LINDA F · 1991 to 1993
–
NHLBI NIH HHS HL084584NHLBI NIH HHS HL084584SNHLBI NIH HHS R01 HL084584
6 · The paper itself

Abstract

ANF-RGC is the prototype receptor membrane guanylate cyclase being both the receptor and the signal transducer of the most hypotensive hormones, ANF and BNP. It is a single transmembrane-spanning protein. After binding these hormones at the extracellular domain it at its intracellular domain signals activation of the C-terminal catalytic module and accelerates the production of its second messenger, cyclic GMP, which controls blood pressure, cardiac vasculature, and fluid secretion. ATP is obligatory for the posttransmembrane dynamic events leading to ANF-RGC activation. It functions through the ATP-regulated module, ARM (KHD) domain, of ANF-RGC. In the current over a decade held model "phosphorylation of the KHD is absolutely required for hormone-dependent activation of NPR-A" [Potter, L. R., and Hunter, T. (1998) Mol. Cell. Biol. 18, 2164-2172]. The presented study challenges this concept. It demonstrates that, instead, ATP allosteric modification of ARM is the primary signaling step of ANF-GC activation. In this two-step new dynamic model, ATP in the first step binds ARM. This triggers in it a chain of transduction events, which cause its allosteric modification. The modification partially activates (about 50%) ANF-RGC and, concomitantly, also prepares the ARM for the second successive step. In this second step, ARM is phosphorylated and ANF-RGC achieves additional (∼50%) full catalytic activation. The study defines a new paradigm of the ANF-RGC signaling mechanism.

Indexed as

Adenosine TriphosphateAllosteric RegulationAnimalsCatalysisChlorocebus aethiopsCOS CellsEnzyme ActivationGuanylate CyclaseModels, BiologicalModels, MolecularMutant ProteinsPhosphorylationReceptors, Atrial Natriuretic FactorValidation Studies as TopicAdenosine TriphosphateGuanylate CyclaseMutant ProteinsReceptors, Atrial Natriuretic Factor

Identifiers

PMID21222471
PMCPMC3049299
OpenAlexW1978781920

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.